Poly Medicure Limited has informed the Exchange regarding Board meeting held on February 05, 2026 for the approval of Unaudited Financial Results (Standalone & Consolidated) for the third quarter and nine months ended on 31st December, 2025 and other business matters.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has informed the exchange that its Board of Directors met on February 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. The meeting also covered other routine business matters. This is a standard intimation of a board meeting held to approve quarterly results, and the actual numbers have not been disclosed in this filing. The detailed financial results are expected to be filed separately.
No direct impact on shareholders from this announcement as it only confirms that a board meeting was held. Investors should wait for the actual Q3 FY26 results to assess the company's performance and any potential impact on the stock price.